Clinical Trial Update: Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the abscopal effect of radiation in combination with rhGM-CSF for metastatic non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• RhGM-CSF (sargramostim (recombinant human granulocyte-macrophage colony-stimulating factor))

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Lung Cancer Metastatic | Phase 2 | Status: COMPLETED